Sensitivity Analyses of the Change in FVC in a Phase 3 Trial of Pirfenidone for Idiopathic Pulmonary Fibrosis

BACKGROUND: FVC outcomes in clinical trials on idiopathic pulmonary fibrosis (IPF) can be substantially influenced by the analytic methodology and the handling of missing data. We conducted a series of sensitivity analyses to assess the robustness of the statistical finding and the stability of the...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Chest
Asıl Yazarlar: Lederer, David J., Bradford, Williamson Z., Fagan, Elizabeth A., Glaspole, Ian, Glassberg, Marilyn K., Glasscock, Kenneth F., Kardatzke, David, King, Talmadge E., Lancaster, Lisa H., Nathan, Steven D., Pereira, Carlos A., Sahn, Steven A., Swigris, Jeffrey J., Noble, Paul W.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American College of Chest Physicians 2015
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4493875/
https://ncbi.nlm.nih.gov/pubmed/25856121
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1378/chest.14-2817
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller